SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE H impact

S&P upgrades Teva to BBB- as MFN talks and notes plan progress

Teva Pharmaceutical Industries Ltd (TEVA) gained investment-grade status after S&P upgraded it to BBB-. Teva also joined nine drugmakers in MFN talks tied to at least $19.6B in U.S. manufacturing investment and plans EUR/USD unsecured notes.

TEVA

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) won investment-grade status as S&P upgraded it to BBB- while joining nine drugmakers in MFN talks that pair at least $19.6B in U.S. manufacturing investment, and plans EUR/USD unsecured notes to refinance debt and fund general corporate needs.Previous…

Related stories